Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$11.6B |
| 2 |
NVIDIA
NVDA
|
+$4.91B |
| 3 |
Microsoft
MSFT
|
+$4.44B |
| 4 |
Amazon
AMZN
|
+$3.61B |
| 5 |
Visa
V
|
+$2.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$1.81B |
| 2 |
Applovin
APP
|
+$1.68B |
| 3 |
Palantir
PLTR
|
+$1.32B |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$1.23B |
| 5 |
Marvell Technology
MRVL
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.5% |
| 2 | Financials | 13.58% |
| 3 | Consumer Discretionary | 10.94% |
| 4 | Healthcare | 10% |
| 5 | Industrials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Espey Mfg & Electronics Corp
ESP
$177M
| $2.43M | ﹤0.01% |
80,700
+9,372
| +13% | +$282K |
|
|
WHWK
3502
Whitehawk Therapeutics
WHWK
$190M
| $2.42M | ﹤0.01% |
765,992
| – | – |
|
3503
Century Therapeutics
IPSC
$364M
| $2.41M | ﹤0.01% |
2,381,707
-93,508
| -4% | -$127K |
|
3504
Mastech Digital
MHH
$93.1M
| $2.4M | ﹤0.01% |
160,977
| – | – |
|
3505
Pixelworks
PXLW
$38.2M
| $2.4M | ﹤0.01% |
273,447
| – | – |
|
3506
iShares MSCI China ETF
MCHI
$6.32B
| $2.39M | ﹤0.01% |
51,055
| – | – |
|
3507
TriSalus Life Sciences
TLSI
$279M
| $2.39M | ﹤0.01% |
476,292
+60,154
| +14% | +$254K |
|
3508
SELLAS Life Sciences
SLS
$1.97B
| $2.38M | ﹤0.01% |
2,292,857
| – | – |
|
|
INGM
3509
Ingram Micro Holding
INGM
$6.51B
| $2.38M | ﹤0.01% |
+122,753
| New | +$2.76M |
|
3510
Atara Biotherapeutics
ATRA
$75.5M
| $2.38M | ﹤0.01% |
178,782
-1,933
| -1% | -$20.4K |
|
3511
Quince Therapeutics
QNCX
$22.9M
| $2.38M | ﹤0.01% |
6,362
+364
| +6% | +$109K |
|
3512
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
| $2.38M | ﹤0.01% |
8,495
+330
| +4% | +$93.3K |
|
3513
374Water
SCWO
$38.1M
| $2.38M | ﹤0.01% |
347,790
+762
| +0.2% | +$9.4K |
|
3514
Broadway Financial
BYFC
$93.8M
| $2.37M | ﹤0.01% |
345,983
-37
| -0% | -$254 |
|
3515
Cibus
CBUS
$147M
| $2.36M | ﹤0.01% |
850,490
+11,538
| +1% | +$44.7K |
|
3516
Annovis Bio
ANVS
$74.4M
| $2.35M | ﹤0.01% |
466,277
+86,022
| +23% | +$623K |
|
3517
One Stop Systems
OSS
$303M
| $2.34M | ﹤0.01% |
699,099
| – | – |
|
3518
Rhinebeck Bancorp
RBKB
$188M
| $2.33M | ﹤0.01% |
242,118
| – | – |
|
3519
Coda Octopus Group
CODA
$114M
| $2.33M | ﹤0.01% |
297,827
-1,968
| -0.7% | -$16.7K |
|
3520
Apyx Medical
APYX
$173M
| $2.33M | ﹤0.01% |
1,475,772
-5,112
| -0.3% | -$7.15K |
|
3521
Immuneering
IMRX
$267M
| $2.33M | ﹤0.01% |
1,056,922
-13,400
| -1% | -$27.8K |
|
|
TSSI
3522
TSS Inc
TSSI
$278M
| $2.32M | ﹤0.01% |
+195,485
| New | +$1.9M |
|
3523
Purple Innovation
PRPL
$35.3M
| $2.32M | ﹤0.01% |
118,841
+143
| +0.1% | +$3.24K |
|
3524
US Gold Corp
USAU
$214M
| $2.3M | ﹤0.01% |
374,450
-4,151
| -1% | -$27.5K |
|
|
AIFC
3525
AI Financial Corp
AIFC
$57.6M
| $2.28M | ﹤0.01% |
490,725
+156,063
| +47% | +$421K |
|
Similar funds
Vanguard Group's Q4 2024 Portfolio in Review
As of Q4 2024, Vanguard Group held 4,397 positions worth $5.74T, up 2.8% from $5.58T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.4%. Vanguard Group opened 46 new positions and exited 103, leaving the 4,397-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2024 buy was Primo Brands: 15,315,211 shares worth $471M.
- Vanguard Group added most to Apple in Q4 2024, an estimated $11.6B increase.
- Vanguard Group's biggest Q4 2024 reduction was Applovin, cutting an estimated $1.68B.
- Vanguard Group fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $1.81B.
- Vanguard Group's ten largest holdings make up 29% of its $5.74T portfolio in Q4 2024.
- Vanguard Group opened 46 new positions and closed 103 in Q4 2024.
- Vanguard Group's portfolio value rose 2.8% quarter-over-quarter to $5.74T.
Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.